Clearance properties of liposomes involving conjugated proteins for targeting

被引:46
作者
Harasym, TO
Bally, MB
Tardi, P
机构
[1] British Columbia Canc Agcy, Dept Adv Therapeut, Vancouver, BC V5Z 4E6, Canada
[2] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada
[3] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada
[4] INEX Pharmaceut Corp, Burnaby, BC V5J 5JB, Canada
关键词
liposomes; protein conjugation;
D O I
10.1016/S0169-409X(97)00134-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review examines methods of protein conjugation onto liposomes and the effects of surface bound protein on the liposomes' biological behavior. it is evident that the presence of a conjugated protein significantly alters the attributes of targeted liposomes. Specifically, protein conjugation can result in dramatic increases in liposome size, enhanced immunogenicity, and increased plasma elimination. Techniques are discussed for preventing some of the physical (size) and biological (immunogenic) alterations involving the use of PEG-lipids and drug loaded liposomes. In addition, the advantages of conjugating antibodies via carbohydrate moieties, to minimize changes in antibody binding and tertiary structure as well as effectively decreasing plasma elimination, ate also discussed, it is, however, apparent that the accessibility of targeted liposomes to extravascular sires is a key step that will require further study and it is, therefore, anticipated that with the development of novel ligands and novel ligand-liposome interactions, the therapeutic utility of targeting strategies will likely be realized. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:99 / 118
页数:20
相关论文
共 133 条
[1]  
ABBAS AK, 1994, CELLULAR MOL IMMUNOL, P34
[2]  
ABRA RM, 1980, RES COMMUN CHEM PATH, V29, P349
[3]  
AHMAD I, 1993, CANCER RES, V53, P1484
[4]   DETERGENT REMOVAL DURING MEMBRANE RECONSTITUTION [J].
ALLEN, TM ;
ROMANS, AY ;
KERCRET, H ;
SEGREST, JP .
BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 601 (02) :328-342
[5]   LIPOSOMES WITH PROLONGED CIRCULATION TIMES - FACTORS AFFECTING UPTAKE BY RETICULOENDOTHELIAL AND OTHER TISSUES [J].
ALLEN, TM ;
HANSEN, C ;
RUTLEDGE, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 981 (01) :27-35
[6]   3-(2-pyridyldithio)propionic acid hydrazide as a cross-linker in the formation of liposome-antibody conjugates [J].
Ansell, SM ;
Tardi, PG ;
Buchkowsky, SS .
BIOCONJUGATE CHEMISTRY, 1996, 7 (04) :490-496
[7]   IMMUNE CLEARANCE OF LIPOSOMES INHIBITED BY AN ANTI-FC RECEPTOR ANTIBODY INVIVO [J].
ARAGNOL, D ;
LESERMAN, LD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (08) :2699-2703
[8]   ENHANCED LOCALIZATION OF LIPOSOMES WITH PROLONGED BLOOD-CIRCULATION TIME IN INFECTED LUNG-TISSUE [J].
BAKKERWOUDENBERG, IAJM ;
LOKERSE, AF ;
TENKATE, MT ;
STORM, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1138 (04) :318-326
[9]   LIPOSOMES WITH ENTRAPPED DOXORUBICIN EXHIBIT EXTENDED BLOOD RESIDENCE TIMES [J].
BALLY, MB ;
NAYAR, R ;
MASIN, D ;
HOPE, MJ ;
CULLIS, PR ;
MAYER, LD .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1023 (01) :133-139
[10]  
BLASER K, 1983, IMMUNOLOGY, V48, P423